Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: India Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
200610
20081
20091
20111
20133
20171
20181
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Kowa Research Europe4
Amarin Pharma Inc.2
Novartis Pharmaceuticals2
89bio, Inc.1
Amgen1
Centre for Chronic Disease Control, India1
Kowa Research Institute, Inc.1
Post Graduate Institute of Medical Education and Research, Chandigarh1
PreEmptive Meds, Pvt. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias23
Diabetes Mellitus, Type 29
Diabetes Mellitus8
Glucose Metabolism Disorders8
Hypercholesterolemia6
Hyperlipidemias4
Hypertriglyceridemia3
Cardiovascular Diseases2
Coronary Artery Disease2
Acute Coronary Syndrome1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.